{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:37:34Z","timestamp":1776742654852,"version":"3.51.2"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Paratek Pharmaceuticals, Inc","award":["G0505124"],"award-info":[{"award-number":["G0505124"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","award":["1P01AI152999"],"award-info":[{"award-number":["1P01AI152999"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","award":["2R01AI139261"],"award-info":[{"award-number":["2R01AI139261"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","award":["T32AI141349"],"award-info":[{"award-number":["T32AI141349"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The epidemic Clostridioides difficile ribotype 027 (RT 027) strain is associated with bacterial virulence traits, including faster germination time and resistance to moxifloxacin, a second-generation fluoroquinolone. Although fluoroquinolones are linked to the RT 027 epidemic, studies to understand moxifloxacin as a high-risk antibiotic for C difficile infection (CDI) are limited. This study assessed the microbial taxonomic profile and metabolomic changes in healthy volunteers given moxifloxacin or oral vancomycin, an antibiotic known to increase CDI risk via gut perturbation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This phase 1, nonblinded, randomized clinical trial comprised healthy volunteers aged 18 to 40 years who received moxifloxacin or vancomycin for 10 days. Stool samples were collected at baseline and 12 follow-up visits. Metataxonomics was completed by 16S rRNA sequencing and bile acid metabolites by liquid chromatography\u2013tandem mass spectrometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Moxifloxacin therapy caused minimal microbial disruption, although changes were observed in bacterial species from the Clostridiales order during therapy. Secondary bile acid concentrations decreased from day 0 to day 7 with moxifloxacin therapy. Vancomycin caused more significant changes in the microbiome, including increased Proteobacteria, decreased Clostridiales abundance, and a longer duration of decreased secondary bile acids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Moxifloxacin use was associated with specific microbiome and metabolomic changes, increasing CDI risk albeit for a shorter period than vancomycin. This window of vulnerability may help to explain the risk of fluoroquinolones with the faster germination time for RT 027 strains.<\/jats:p>\n                    <jats:p>Clinical Trials Registration. \u00a0ClinicalTrials.gov NCT06030219.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf512","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:02:39Z","timestamp":1760097759000},"page":"1446-1456","source":"Crossref","is-referenced-by-count":1,"title":["A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for\n                    <i>Clostridioides difficile<\/i>\n                    Risk"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0596-4996","authenticated-orcid":false,"given":"Hossaena","family":"Ayele","sequence":"first","affiliation":[{"name":"Center for Infectious Diseases, UTHealth Houston School of Public Health, University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhee","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurshida","family":"Begum","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-2127","authenticated-orcid":false,"given":"Chenlin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh M","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Jahangir","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-406X","authenticated-orcid":false,"given":"Taryn A","family":"Eubank","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigmund J","family":"Haidacher","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children's Hospital , Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-3484","authenticated-orcid":false,"given":"Thomas D","family":"Horvath","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"},{"name":"Department of Pathology and Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children's Hospital , Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2949-7818","authenticated-orcid":false,"given":"Blake M","family":"Hanson","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, UTHealth Houston School of Public Health, University of Texas Health Science Center at Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7503","authenticated-orcid":false,"given":"Kevin W","family":"Garey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research College of Pharmacy, University of Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2026031304481040600_jiaf512-B1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1053\/j.gastro.2014.01.059","article-title":"Role of the intestinal microbiota in resistance to colonization by Clostridium difficile","volume":"146","author":"Britton","year":"2014","journal-title":"Gastroenterology"},{"key":"2026031304481040600_jiaf512-B2","doi-asserted-by":"crossref","first-page":"2223345","DOI":"10.1080\/19490976.2023.2223345","article-title":"Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies","volume":"15","author":"Gonzales-Luna","year":"2023","journal-title":"Gut Microbes"},{"key":"2026031304481040600_jiaf512-B3","doi-asserted-by":"crossref","first-page":"2094672","DOI":"10.1080\/19490976.2022.2094672","article-title":"Gut associated metabolites and their roles in Clostridioides difficile pathogenesis","volume":"14","author":"Aguirre","year":"2022","journal-title":"Gut Microbes"},{"key":"2026031304481040600_jiaf512-B4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/AEM.66.3.1107-1113.2000","article-title":"Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces","volume":"66","author":"Wells","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"2026031304481040600_jiaf512-B5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/JCM.02250-16","article-title":"Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing","volume":"55","author":"Peng","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026031304481040600_jiaf512-B6","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1038\/srep12666","article-title":"Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model","volume":"5","author":"Yakob","year":"2015","journal-title":"Sci Rep"},{"key":"2026031304481040600_jiaf512-B7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/22221751.2020.1721335","article-title":"PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255","volume":"9","author":"Gonzales-Luna","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2026031304481040600_jiaf512-B8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijid.2019.10.038","article-title":"The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016","volume":"90","author":"Novakova","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2026031304481040600_jiaf512-B9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in US burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"key":"2026031304481040600_jiaf512-B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anaerobe.2016.05.006","article-title":"Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection","volume":"41","author":"Ross","year":"2016","journal-title":"Anaerobe"},{"key":"2026031304481040600_jiaf512-B11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N Engl J Med"},{"key":"2026031304481040600_jiaf512-B12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1099\/jmm.0.056614-0","article-title":"Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failure","volume":"62","author":"Moore","year":"2013","journal-title":"J Med Microbiol"},{"key":"2026031304481040600_jiaf512-B13","doi-asserted-by":"crossref","first-page":"ofz013","DOI":"10.1093\/ofid\/ofz013","article-title":"Epidemic Clostridioides difficile ribotype 027 lineages: comparisons of Texas versus worldwide strains","volume":"6","author":"Endres","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2026031304481040600_jiaf512-B14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng.2478","article-title":"Emergence and global spread of epidemic healthcare-associated Clostridium difficile","volume":"45","author":"He","year":"2013","journal-title":"Nat Genet"},{"key":"2026031304481040600_jiaf512-B15","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/AAC.45.8.2348-2353.2001","article-title":"Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA","volume":"45","author":"Ackermann","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2026031304481040600_jiaf512-B16","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/AAC.01582-06","article-title":"Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice","volume":"51","author":"Adams","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026031304481040600_jiaf512-B17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00003495-199958002-00013","article-title":"Effect of quinolones on intestinal ecology","volume":"58","author":"Edlund","year":"1999","journal-title":"Drugs"},{"key":"2026031304481040600_jiaf512-B18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/AAC.00306-08","article-title":"Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model","volume":"53","author":"Saxton","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026031304481040600_jiaf512-B19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.anaerobe.2011.03.015","article-title":"Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones","volume":"17","author":"Phillips","year":"2011","journal-title":"Anaerobe"},{"key":"2026031304481040600_jiaf512-B20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1592\/phco.23.14.1517.31936","article-title":"Moxifloxacin-induced Clostridium difficile\u2013associated diarrhea","volume":"23","author":"Carroll","year":"2003","journal-title":"Pharmacotherapy"},{"key":"2026031304481040600_jiaf512-B21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fcimb.2019.00099","article-title":"Antibiotic-induced disruption of gut microbiota alters local metabolomes and immune responses","volume":"9","author":"Sun","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2026031304481040600_jiaf512-B22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/jiad537","article-title":"Fecal pharmacokinetics and gut microbiome effects of oral omadacycline versus vancomycin in healthy volunteers","volume":"229","author":"Jo","year":"2024","journal-title":"J Infect Dis"},{"key":"2026031304481040600_jiaf512-B23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkw383","article-title":"Short- and long-term effects of oral vancomycin on the human intestinal microbiota","volume":"72","author":"Isaac","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026031304481040600_jiaf512-B24","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1038\/s41598-019-46535-8","article-title":"Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma","volume":"9","author":"Walker","year":"2019","journal-title":"Sci Rep"},{"key":"2026031304481040600_jiaf512-B25","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","article-title":"Search and clustering orders of magnitude faster than BLAST","volume":"26","author":"Edgar","year":"2010","journal-title":"Bioinformatics"},{"key":"2026031304481040600_jiaf512-B26","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1128\/AEM.00062-07","article-title":"Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"2026031304481040600_jiaf512-B27","doi-asserted-by":"crossref","first-page":"106020","DOI":"10.1016\/j.mimet.2020.106020","article-title":"Ruggedness testing of liquid chromatography\u2013tandem mass spectrometry system components using microbiome-relevant methods and matrices","volume":"177","author":"Horvath","year":"2020","journal-title":"J Microbiol Methods"},{"key":"2026031304481040600_jiaf512-B28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/cts.12761","article-title":"Impact of vancomycin-induced changes in the intestinal microbiota on the pharmacokinetics of simvastatin","volume":"13","author":"Sunwoo","year":"2020","journal-title":"Clin Transl Sci"},{"key":"2026031304481040600_jiaf512-B29","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/jac\/dkaa364","article-title":"A randomized, double-blind, placebo-controlled, single and multiple ascending dose phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects","volume":"75","author":"Garey","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026031304481040600_jiaf512-B30","author":"Oksanen"},{"key":"2026031304481040600_jiaf512-B31","doi-asserted-by":"crossref","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","article-title":". Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One"},{"key":"2026031304481040600_jiaf512-B32","doi-asserted-by":"crossref","first-page":"e67019","DOI":"10.1371\/journal.pone.0067019","article-title":"ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-seq","volume":"8","author":"Fernandes","year":"2013","journal-title":"PLoS One"},{"key":"2026031304481040600_jiaf512-B33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"2026031304481040600_jiaf512-B34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.anaerobe.2016.05.003","article-title":"Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract","volume":"41","author":"Winston","year":"2016","journal-title":"Anaerobe"},{"key":"2026031304481040600_jiaf512-B35","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/ncomms4114","article-title":"Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection","volume":"5","author":"Theriot","year":"2014","journal-title":"Nat Commun"},{"key":"2026031304481040600_jiaf512-B36","doi-asserted-by":"crossref","first-page":"e00820","DOI":"10.1128\/AAC.00820-19","article-title":"Impact of antibiotic gut exposure on the temporal changes in microbiome diversity","volume":"63","author":"Burdet","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026031304481040600_jiaf512-B37","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2015-04-638858","article-title":"Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome","volume":"126","author":"Weber","year":"2015","journal-title":"Blood"},{"key":"2026031304481040600_jiaf512-B38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/19490976.2018.1502536","article-title":"Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales","volume":"10","author":"Farowski","year":"2019","journal-title":"Gut Microbes"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf512\/64659364\/jiaf512.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/6\/1446\/64659364\/jiaf512.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/6\/1446\/64659364\/jiaf512.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:48:33Z","timestamp":1773391713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/6\/1446\/8284853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,10,13]]},"published-print":{"date-parts":[[2025,12,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf512","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,15]]},"published":{"date-parts":[[2025,10,13]]}}}